Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.410
+0.060 (4.44%)
At close: Apr 15, 2026, 4:00 PM EDT
1.380
-0.030 (-2.13%)
Pre-market: Apr 16, 2026, 6:08 AM EDT

Lucid Diagnostics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4.714.352.430.380.5
Revenue Growth (YoY)
8.28%79.00%544.03%-24.60%-
Cost of Revenue
6.677.15.983.610.59
Gross Profit
-1.96-2.75-3.55-3.24-0.09
Selling, General & Admin
41.5836.6235.6640.1118.04
Depreciation & Amortization Expenses
0.420.692.021.65-
Research & Development
5.685.997.2511.269.3
Total Operating Expenses
47.6843.344.9353.0127.33
Operating Income
-49.64-46.05-48.48-56.25-27.42
Interest Income
0.390.320.420.09-
Interest Expense
-0.02-0.03-0.42-0.01-0.66
Other Non-Operating Income (Expense)
-8.730.23-4.19--
Total Non-Operating Income (Expense)
-8.370.52-4.180.08-0.66
Pretax Income
-58.01-45.53-52.67-56.17-28.08
Net Income
-70.57-53.03-52.67-56.17-28.08
Net Income Attributable to Preferred Dividends
12.567.5---
Net Income to Common
-70.57-53.03-52.67-56.17-28.08
Shares Outstanding (Basic)
10251506327
Shares Outstanding (Diluted)
10251506327
Shares Change (YoY)
101.81%0.81%-19.84%133.33%31.80%
EPS (Basic)
-0.69-1.05-1.05-0.90-1.05
EPS (Diluted)
-0.69-1.05-1.05-0.90-1.05
Shares Outstanding
131.163.0750.858.3550.28
Free Cash Flow
-46.68-44.44-33.04-30.59-18.53
Free Cash Flow Per Share
-0.46-0.88-0.66-0.49-0.69
Gross Margin
-41.73%-63.35%-146.25%-858.62%-17.00%
Operating Margin
-1054.82%-1059.64%-1996.79%-14920.70%-5483.80%
Profit Margin
-1232.68%-1047.61%-2169.11%-14899.50%-5615.60%
FCF Margin
-991.97%-1022.46%-1360.71%-8114.85%-3706.00%
EBITDA
-48.77-44.89-45.98-54.32-27.42
EBITDA Margin
-1036.29%-1032.79%-1893.86%-14407.20%-5483.00%
EBIT
-49.64-46.05-48.48-56.25-27.42
EBIT Margin
-1054.82%-1059.64%-1996.79%-14920.70%-5483.80%
Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q